Type
      
    . [Results of six-month treatment of paucibacillary leprosy patients with rifampicin and dapsone]. Chinese Journal of Dermatology. 1988;21(6):355-357 . 
Type
      
    . [Associated factors with irregular intake of Dapsone in leprosy patients]. Revista de la Universidad Industrial de Santander. Salud [Internet]. 2013;45(1):7-14. Available from: http://www.scielo.org.co/pdf/suis/v45n1/v45n1a02.pdf
Type
      
    . Considerations on clinical trials of leprosy treatment: need of novel drug combinations. Clinical Investigation  [Internet]. 2013;3(7):617-635 . Available from: http://www.future-science.com/doi/pdf/10.4155/cli.13.52
Type
      
    . Leprosy treatment dropout: a sistematic review. International Archives of Medicine [Internet]. 2013;6(1):34. Available from: http://www.intarchmed.com/content/pdf/1755-7682-6-34.pdf
Type
      
    Editor’s Choice June 2012: Scales for measuring everything. Leprosy review. 2012;83:119 - 120. 
Type
      
    . Clinical variables associated with leprosy reactions and persistence of physical impairment. Revista da Sociedade Brasileira de Medicina Tropical [Internet]. 2013;46(5):600-604. Available from: http://www.scielo.br/pdf/rsbmt/v46n5/0037-8682-rsbmt-42-2013.pdf
Type
      
    . Successful treatment of osteomyelitis in leprosy patients by homeopathic medicine. Exploratory Animal and Medical Research [Internet]. 2013;3(2):169-177. Available from: http://animalmedicalresearch.org/Vol.3_Issue-2_December_2013/D%20Chakraborty.pdf
Type
      
    . Anti-leprosy drug Clofazimine inhibits growth of triple-negative breast cancer cells via inhibition of canonical Wnt signaling. Biochemical pharmacology. 2013;. 
Type
      
    . Borderline tuberculoid leprosy and type 1 leprosy reaction in a hepatitis C patient during treatment with interferon and ribavirin. Anais brasileiros de dermatologia [Internet]. 2013;88(6 Suppl 1):109-12. Available from: http://www.scielo.br/pdf/abd/v88n6s1/0365-0596-abd-88-06-s1-0109.pdf
Type
      
    . Lucio's Phenomenon. Case study of an exceptional response to treatment exclusively with multibacillary multidrug therapy. Anais brasileiros de dermatologia [Internet]. 2013;88(6 Suppl 1):93-6. Available from: http://www.scielo.br/pdf/abd/v88n6s1/0365-0596-abd-88-06-s1-0093.pdf
Pagination
- Previous page
 - Page 34
 - Next page